Thomas Addison

Covance (United States)

Papers

1

Total Citations

62

H-Index

1

About

Thomas Addison is a leading figure in bioanalytical chemistry, with a specialized focus on the development and validation of high-performance liquid chromatography/tandem mass spectrometry (LC/MS/MS) methods for therapeutic drug monitoring. His most influential work, a 2002 paper detailing a robust LC/MS/MS method for quantifying ribavirin in human plasma and serum, has garnered over 60 citations and remains a foundational reference in antiviral pharmacokinetics. This contribution established a gold-standard protocol for accurately measuring ribavirin concentrations, directly supporting clinical studies on hepatitis C and other viral infections. Addison’s research is characterized by rigorous method validation, ensuring reproducibility and sensitivity critical for both preclinical and clinical applications. His work has enabled researchers to better understand drug metabolism and optimize dosing regimens, bridging the gap between analytical chemistry and patient care. By providing reliable tools for bioanalysis, Addison has significantly advanced the field of pharmaceutical analysis, making him a key resource for scientists developing new antiviral therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
62
Total Citations
62
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum
62 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Covance (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago